Genetic flaw may hold key to deadly childhood brain tumour

April 7, 2014, Cancer Research UK

Scientists may have discovered a new way to treat a type of childhood brain tumour that has proved incurable up until now, according to a study published in Nature Genetics today.

When Cancer Research UK funded scientists at The Institute of Cancer Research, London, studied biopsy samples from a type of childhood glioma called diffuse intrinsic pontine glioma, or DIPG, they found that a quarter of them had an extremely rare genetic flaw which could be a potential new drug target. These findings were backed up by additional studies – also published in today's Nature Genetics – carried out in collaboration with scientists in North America.

This flaw has not been found in any other type of cancer, but is also found in patients with a childhood development disorder known as Stone Man Syndrome, also known as fibrodysplasia ossificans progressiva, or FOP, where muscles can turn into bone.

If the genetic flaw is present in all cells of the body then a child will develop FOP, however if it only occurs in the brain then it could lead to DIPG, which is universally fatal.

Crucially, drugs are already being developed to treat this developmental syndrome, and it's hoped that the same drugs might also help children with this rare form of .

Study leader Dr Chris Jones, Head of the Glioma Team at The Institute of Cancer Research, London, said: "Our study has uncovered a remarkable genetic link between two very different but distressing diseases – a rare inherited condition that turns muscles into bone, and a deadly form of cancer.

"We believe that the genetic defect linking these diseases is a potential target for cancer therapies, not least because drugs already exist against similar targets in other cancers. Understanding the link between fibrodysplasia ossificans progressiva and diffuse intrinsic pontine glioma could offer new hope to patients and their families affected by both conditions."

This particular form of glioma is a childhood that affects between 20-30 children a year in the UK. The average survival is less than a year and there is currently no effective treatment.

The study is part of the Cancer Research UK Genomics Initiative, which is funded by Cancer Research UK through the Catalyst Club – a pioneering venture to raise £10 million for various research projects aimed at realising the benefits of personalised medicine for people with cancer.

Nell Barrie, Cancer Research UK's senior science communication manager, said: "Although almost eight in 10 children with now survive their disease, there is still a long way to go for certain childhood cancers. Further research is essential to discovering better and kinder treatments, particularly for brain tumours. Studies like this lay the groundwork for future treatments to ensure that there are more in the years to come."

Explore further: New imaging approach fast tracks drug testing for incurable prostate cancer

More information: Taylor, K. Et al. "Recurrent activating ACVR1/ALK2 mutations in diffuse intrinsic pontine glioma." Nature Genetics (2014). 

Related Stories

New imaging approach fast tracks drug testing for incurable prostate cancer

March 17, 2014
Cancer Research UK-funded scientists have developed a new way to test the effectiveness of a drug for prostate cancer that has spread to the bone, which is currently incurable, according to research published in the Journal ...

Team finds potential drug targets in deadly pediatric brain tumors

April 6, 2014
Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study from scientists at Dana-Farber/Boston Children's Cancer and Blood ...

Novel study into breast cancer origins paves way for personalized treatment

March 31, 2014
Breast cancers can look and behave very differently. Understanding why and how they do so is key to designing more tailored therapies for patients and sparing them unnecessary treatments.

Genetic profiling tracks progression from manageable blood cancer into deadly disease

December 23, 2013
Genetic profiling has painted the clearest picture yet of how a type of blood cancer – follicular lymphoma – develops and changes from a manageable disease into an aggressive cancer, offering new targets for treatment, ...

Mutations in leukemia gene linked to new childhood growth disorder

March 9, 2014
Mutations in a gene associated with leukaemia cause a newly described condition that affects growth and intellectual development in children, new research reports.

New role for DNA unraveler in preventing brain tumours and other cancers

October 11, 2013
(Medical Xpress)—A molecule originally implicated in DNA repair may also be a crucial factor in preventing tumours such as medulloblastoma, a type of childhood brain tumour, according to research published today in Science.

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.